Reminder: DUA and VRDC access needs to be extended or renewed annually. Read more.
SAS Name
HER2_AMPLIFICATION
HER2 amplification.
Source: Oncology Care Model Data Registry
| Code | Code value |
|---|---|
| None Selected | |
| Not Tested | |
| Equivocal | |
| Negative | |
| Positive | |
| Null/missing | n/a (not breast gastro/esophageal cancer); or not reported by OCM participant (reference details in the RPTD_TO_RGSTRY codebook entry) |
Practices were required to report clinical and staging data associated with each beneficiary’s assigned cancer. HER2 Amplification is routinely tested for breast cancer and gastro/esophageal cancer. It is necessary for breast cancer staging and helps determine treatment decisions. This variable is only populated for episodes with breast cancer or gastro/esophageal cancer.